DSGN compared with FTH: revenue, margins and what each company keeps, and the suppliers and customers both name

DSGNDesign Therapeutics, Inc.

Mkt capRevenueRevenue

FTHFaeth Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

DSGNDesign Therapeutics, Inc.

FTHFaeth Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

DSGN: latest quarter not drawable. FTH: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only DSGN 4

—Wisconsin Alumni Research Foundation (WARF)unlistedsupplier

—Crossingunlistedsupplier

—Marlinspikeunlistedsupplier

—TREF V Hidden Valley Ownerunlistedsupplier

Shared 0

No shared counterparties.

Only FTH 2

TAKTakeda Pharmaceuticalsupplier

—The Regents of the University of Californiaunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

DSGN, solidFTH, dashed

DSGNDesign Therapeutics, Inc.

10.66▼−3.62%· post 10.66

Mkt cap$668.4M

FTHFaeth Therapeutics, Inc.

18.21▼−2.89%· post 18.32

ClosedOct 30 '26

Mkt cap$483.0M

Compare

ClosedOct 30 '26

DSGNDesign Therapeutics, Inc.

FTHFaeth Therapeutics, Inc.

10.66▼−3.62%post 10.66

Price

18.21▼−2.89%post 18.32

$668.4M

Mkt cap

$483.0M

DSGN10.66▼−3.62%vsFTH18.21▼−2.89%ClosedOct 30 '26